Drugs / ranitidine bismuth citrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02004197 | Jan 2010 → Sep 2012 | Helicobacter pylori infectious disease | Hafiz Muhammad Asif | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ranitidine bismuth citrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02004197 ↗ |
| Known as | TRITEC (ranitidine bismuth citrate) | “TRITEC (ranitidine bismuth citrate)” NCT02004197 ↗ |